# PRospective Prostate biOmarker Study

> **NCT03565289** · — · COMPLETED · sponsor: **ProteoMediX AG** · enrollment: 455 (actual)

## Conditions studied

- Indication for Prostate Biopsy Due to Suspected Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Blood sample collection

## Key facts

- **NCT ID:** NCT03565289
- **Lead sponsor:** ProteoMediX AG
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-14
- **Primary completion:** 2019-12-31
- **Final completion:** 2020-01-31
- **Target enrollment:** 455 (ACTUAL)
- **Last updated:** 2020-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03565289

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03565289, "PRospective Prostate biOmarker Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03565289. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*